develops novel small molecule cancer therapeutics based on "Activated Checkpoint Therapy"

History:

Cyclis Pharmaceuticals was acquired by ArQule in 2003.

Employment

Email:careers@cyclispharma.com

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northeast

Research Focus:
Disease Therapeutics-Research

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: